SunstarTV Bureau: Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation (WHO) which enabling its recipients to travel abroad without mandatory quarantine.
The information has given by NITI Aayog’s Member, Health, V.K. Paul on Wednesday.
“A positive decision regarding matter may come soon by the month end,” said Paul.
“We must give time to WHO to make their decisions based on science. However, we hope that these decisions can be taken quickly because people who are receiving Covaxin have certain imperatives of travel. Most of us, who chose the concurrency, is important in terms of licensure. We are hoping for an early decision,” Dr Paul said.
In August, Indian Health Minister Mansukh Mandaviya also met WHO Chief Scientist Dr Soumya Swaminathan and held discussions over the WHO approval of Covaxin.
The vaccine’s developer Bharat Biotech has submitted its Phase 3 clinical trials data that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
Notably, the WHO has so far approved Pfizer-BioNTech, AstraZeneca, Johnson and Johnson, Moderna, and Sinopharm Covid-19 vaccines.
